CBD is well tolerated in humans with doses up to 600 mg not resulting in psychotic symptoms (15). In the few small placebo-controlled studies performed, no significant CNS effects were noted. Oral CBD undergoes extensive first-pass metabolism via CYP3A4, with a bioavailability of 6%. Following single doses in humans, the half-life of CBD when taken orally is about 1 to 2 days.1 In vitro studies have shown that CBD is a potent inhibitor of multiple CYP isozymes, including CYP 2C and CYP3A (16, 17). Whether these in vitro observations are relevant at plasma concentrations likely to be seen in patients is unclear. In addition, given its metabolism via CYP3A4, clinical trials of CBD in patients receiving enzyme-inducing AEDs, such as carbamazepine or phenytoin, will require detailed pharmacokinetic studies.
Charlotte’s Web is currently one of the top CBD hemp brands in the U.S and is constantly featured on top authority websites such as The Wall Street Journal, Time and The Huffington Post. What started off as a hemp strain packed with CBD to help a girl named Charlotte Figi, soon turned into an empire. Today, Charlotte’s Web, formerly known as CWhemp offers a wide range of high-quality products including oils, capsules and even CBD gummies. Want to learn more check out our Charlotte’s Web CBD oil Review.